Recent Patents on Drug Delivery & Formulation
Title:Patent Selections:
Volume: 7 Issue: 1
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections:, Recent Patents on Drug Delivery & Formulation 2013; 7 (1) . https://dx.doi.org/10.2174/1872211311307010010
DOI https://dx.doi.org/10.2174/1872211311307010010 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
9
Related Articles
-
Vital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Current Neurovascular Research An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy
Current Cancer Drug Targets A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors
Letters in Drug Design & Discovery Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons
Current Drug Targets N-acetyl-cysteine in Schizophrenia: Potential Role on the Sensitive Cysteine Proteome
Current Medicinal Chemistry Psychiatric/Psychosocial Rehabilitation (PSR) in Relation to Vocational and Educational Environments: Work and Learning
Current Psychiatry Reviews Acid-Sensing Ion Channels: A Novel Therapeutic Target for Pain and Anxiety
Current Pharmaceutical Design Modern Therapeutic Strategies for Autoimmune Diseases
Current Pharmaceutical Design Biomarkers, Biosensors and Biomedicine
Current Medicinal Chemistry Effects of Static Magnetic Fields on Blood Pressure in Animals and Humans
Current Hypertension Reviews Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Current Drug Delivery Neuroactive Steroids as Targets for Development of Novel Pain Therapies
Current Medicinal Chemistry - Central Nervous System Agents Physiological Functions of Presenilins; Beyond γ-Secretase
Current Pharmaceutical Biotechnology CD26 / Dipeptidyl Peptidase IV: A Regulator of Immune Function and a Potential Molecular Target for Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Endocannabinoid System and Pain
CNS & Neurological Disorders - Drug Targets Apolipoprotein E4 Serum Concentration for Increased Sensitivity and Specificity of Diagnosis of Drug Treated Alzheimer’s Disease Patients vs. Drug Treated Parkinson’s Disease Patients vs. Age-matched Normal Controls
Current Alzheimer Research Similar Mechanisms Regulated by γ-Secretase are Involved in Both Directions of the Bi-Directional Notch-Delta Signaling Pathway as well as Play a Potential Role in Signaling Events Involving Type 1 Transmembrane Proteins
Current Stem Cell Research & Therapy Editorial
Recent Patents on CNS Drug Discovery (Discontinued) Transcriptional Regulation Analysis of Alzheimer's Disease Based on FastNCA Algorithm
Current Bioinformatics